Showing results (181-190 of 759) with videos related to

Sort By:
Pageof 76
Journal of the American Society of Nephrology : JASN|September 1, 2012
Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetesPiero Ruggenenti, Esteban Porrini, Nicola Motterlini, et al.
Hypertension (Dallas, Tex. : 1979)|March 17, 2010
Effect of the urotensin receptor antagonist palosuran in hypertensive patients with type 2 diabetic nephropathyLiffert Vogt, Carlos Chiurchiu, Harbajan Chadha-Boreham, et al.
Journal of the American Society of Nephrology : JASN|February 1, 2014
Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndromePiero Ruggenenti, Barbara Ruggiero, Paolo Cravedi, et al.
Diabetes Care|July 10, 2012
Glomerular hyperfiltration and renal disease progression in type 2 diabetesPiero Ruggenenti, Esteban L Porrini, Flavio Gaspari, et al.
Kidney International Reports|October 27, 2025
Randomized Trial of Dapagliflozin in Patients With Nondiabetic Stage 4 CKDMatias Trillini, Alessandro Villa, Annalisa Perna, et al.
Current Opinion in Nephrology and Hypertension|April 13, 2006
Progression of chronic kidney disease: insights from animal modelsCarla Zoja, Mauro Abbate, Giuseppe Remuzzi
Human Immunology|December 31, 2017
Mesenchymal stromal cells for tolerance induction in organ transplantationFederica Casiraghi, Norberto Perico, Giuseppe Remuzzi
Science and Engineering Ethics|October 2, 2002
Conflict of interest as seen from a researcher's perspectiveArrigo Schieppati, Norberto Perico, Giuseppe Remuzzi
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|November 1, 2016
[Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): Somatostatin analogues and mTOR inhibitors]Norberto Perico, Monica Cortinovis, Giuseppe Remuzzi
Current Opinion in Critical Care|September 22, 2005
The hemolytic uremic syndromesJessica Caprioli, Li Peng, Giuseppe Remuzzi
Pageof 76